1. Home
  2. ANNX vs TTSH Comparison

ANNX vs TTSH Comparison

Compare ANNX & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANNX
  • TTSH
  • Stock Information
  • Founded
  • ANNX 2011
  • TTSH 1985
  • Country
  • ANNX United States
  • TTSH United States
  • Employees
  • ANNX N/A
  • TTSH N/A
  • Industry
  • ANNX Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • ANNX Health Care
  • TTSH Finance
  • Exchange
  • ANNX Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • ANNX 253.8M
  • TTSH 264.5M
  • IPO Year
  • ANNX 2020
  • TTSH N/A
  • Fundamental
  • Price
  • ANNX $2.06
  • TTSH $6.21
  • Analyst Decision
  • ANNX Strong Buy
  • TTSH
  • Analyst Count
  • ANNX 5
  • TTSH 0
  • Target Price
  • ANNX $13.00
  • TTSH N/A
  • AVG Volume (30 Days)
  • ANNX 1.2M
  • TTSH 49.0K
  • Earning Date
  • ANNX 08-14-2025
  • TTSH 08-07-2025
  • Dividend Yield
  • ANNX N/A
  • TTSH N/A
  • EPS Growth
  • ANNX N/A
  • TTSH N/A
  • EPS
  • ANNX N/A
  • TTSH N/A
  • Revenue
  • ANNX N/A
  • TTSH $340,228,000.00
  • Revenue This Year
  • ANNX N/A
  • TTSH N/A
  • Revenue Next Year
  • ANNX N/A
  • TTSH N/A
  • P/E Ratio
  • ANNX N/A
  • TTSH N/A
  • Revenue Growth
  • ANNX N/A
  • TTSH N/A
  • 52 Week Low
  • ANNX $1.29
  • TTSH $4.62
  • 52 Week High
  • ANNX $7.85
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • ANNX 38.44
  • TTSH 47.41
  • Support Level
  • ANNX $2.06
  • TTSH $5.64
  • Resistance Level
  • ANNX $2.36
  • TTSH $6.88
  • Average True Range (ATR)
  • ANNX 0.17
  • TTSH 0.35
  • MACD
  • ANNX -0.03
  • TTSH 0.05
  • Stochastic Oscillator
  • ANNX 1.52
  • TTSH 45.97

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: